BEAM – beam therapeutics inc. (US:NASDAQ)
Stock Stats
News
Beam Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Beam Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Beam Therapeutics Inc. (NASDAQ: BEAM) was upgraded by analysts at Cantor Fitzgerald to a "hold" rating.
Beam Therapeutics Inc. (NASDAQ: BEAM) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $57.00 price target on the stock.
Beam Therapeutics Inc. (NASDAQ: BEAM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $80.00 price target on the stock.
Form 4 Beam Therapeutics Inc. For: Dec 17 Filed by: Ciaramella Giuseppe
Form 3 Beam Therapeutics Inc. For: Dec 19 Filed by: Emany Sravan Kumar
Form 8-K Beam Therapeutics Inc. For: Dec 07
Form 8-K Beam Therapeutics Inc. For: Dec 05
Form 4 Beam Therapeutics Inc. For: Dec 02 Filed by: Guindo Chirfi
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.